NCT01802489View on ClinicalTrials.gov

Amiloride Clinical Trial In Optic Neuritis

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Optic NeuritisMultiple Sclerosis
Interventions
DRUG

Amiloride

DRUG

Placebo

Placebo capsule identical in appearance to Amiloride 10mg capsule

Trial Locations (1)

OX3 9DU

John Radcliffe Hospital, Oxford

All Listed Sponsors
collaborator

Multiple Sclerosis Society of Great Britain and Northern Ireland

UNKNOWN

lead

University of Oxford

OTHER

NCT01802489 - Amiloride Clinical Trial In Optic Neuritis | Biotech Hunter | Biotech Hunter